top of page

DOLOMITE - Safety and effectiveness of DTG use in pregnancy


A multi-site observational study to define the safety and effectiveness of Dolutegravir use in HIV positive pregnant women


Indication:  HIV positive women receiving DTG (at least 200 starting or on DTG in the first trimester)


Phase: IV


Countries:  UK, spain, Portugal, France, Italy, Belgium, Poland & Ukraine

Sites: 21 & Counting


Status: Actively recruiting

bottom of page